Compare ABEO & IMSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ABEO | IMSR |
|---|---|---|
| Founded | 1974 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 281.0M | 233.8M |
| IPO Year | 1980 | N/A |
| Metric | ABEO | IMSR |
|---|---|---|
| Price | $5.18 | $9.05 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $18.20 | N/A |
| AVG Volume (30 Days) | 1.2M | ★ 2.7M |
| Earning Date | 11-12-2025 | 02-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.29 | N/A |
| Revenue | ★ $400,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1,589.77 | N/A |
| P/E Ratio | $4.01 | ★ N/A |
| Revenue Growth | N/A | ★ 1234.25 |
| 52 Week Low | $3.93 | $5.95 |
| 52 Week High | $7.54 | $31.50 |
| Indicator | ABEO | IMSR |
|---|---|---|
| Relative Strength Index (RSI) | 50.82 | N/A |
| Support Level | $5.11 | N/A |
| Resistance Level | $5.40 | N/A |
| Average True Range (ATR) | 0.22 | 0.00 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 49.33 | 0.00 |
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
Terrestrial Energy Inc is an industry-leading technology company committed to delivering reliable, emission-free, and cost-competitive nuclear energy with a transformative advanced reactor, the Integral Molten Salt Reactor (IMSR). Its mission is to transform global energy markets by commercializing its IMSR Plant, which will deliver low-carbon electricity and industrial heat with superior economics, speed to deployment, and siting flexibility.